Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 801–900 of 1,000
Alshelaiel, R., Alkushi, A. O., Alriyees, L., Alamro, A. A., Alanazi, H., Alhareeri, A. A., Almuzzaini, B., & Rashid, M. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1606828 · Cited by 2
“T regulatory cells (Tregs) (Zhu et al., 2022), alternatively activated macrophages (M2 macrophages) (Hao et al., 2012), and tumor-associated dendritic cells (TADCs) (Hsu et al., 2018) can contribute to tumor progression and metastasis.”
Xiao, L., Zhang, Z., Li, T., Jiang, Y., Liu, Y., Wang, J., & Tang, W. (2025) · Human Mutation · doi:10.1155/humu/8856239 · Cited by 2
Self-citationFeng, L., & Shi, W. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06318-3 · Cited by 2
“Functionally, they inhibit inflammation, support angiogenesis and fibro - sis, and facilitate tumour development (Hao et al. 2012; Liao et al. 2011 ; Mosser and Edwards, 2008; Satoh et al. 2010 ).”
Kawarizadeh, K., Vallez, C. N., Aliyazdi, S., Warrick, K. A., Carafice, C., Saha, I., & Pasare, C. (2025) · iScience · doi:10.1016/j.isci.2025.113723 · Cited by 2
“3 To perform these critical functions, macrophages express a wide range of surface receptors so as to respond to microenvironmental cues and modulate their behavior along an inflammatory spectrum.”
Dziąg-Dudek, E., Semeniuk-Wojtaś, A., Modzelewska, M., Lubas, A., Róg, L., Górnicka, B., & Stec, R. (2026) · Cancers · doi:10.3390/cancers18040566 · Cited by 2
The M1 Paradox: Pro-Tumorigenic Effect of Macrophage Cytotoxicity in Prostate Cancer
Kovaleva, O. V., Sinyov, V. V., Rashidova, M. A., Malashenko, O. S., Алексеевна, П. П., Kopnin, P., Vassileva, M. V., Balkin, A. S., Plotnikov, A. O., & Gratchev, A. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083655 · Cited by 2
“M1 macrophages are characterized by cytotoxic activity, production of inflammatory cytokines, and the ability to eliminate infected or transformed cells, whereas M2 macrophages are associated with tissue repair, immune suppression, and resolution of inflammation [2,3].”
Zagożdżon, R., & Lasek, W. (2016) · SpringerBriefs in immunology · doi:10.1007/978-3-319-46906-5_1 · Cited by 2
Hiller, J. G., Schier, R., & Riedel, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-57943-6_4 · Cited by 3
Hemke, R., Takayesu, J., Hughes, K. S., Chang, C. Y., DeLaney, T. F., Bernstein, K. D. A., & Bredella, M. A. (2020) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001066 · Cited by 2
Two predicted models based on ceRNAs and immune cells in lung adenocarcinoma
Zhang, M., Zheng, P., Wang, Y., & Sun, B. (2021) · PeerJ · doi:10.7717/peerj.11029 · Cited by 2
Almousa, S., Casals, R. K., Langsten, K. L., & Said, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00040-2 · Cited by 3
Role of macrophages in tumor development
Karim, M. R., Hossain, D., Uddin, A. M., & Rume, F. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822368-0.00007-4 · Cited by 3
Russo, E., Boem, F., Curini, L., & Amedei, A. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_6 · Cited by 2
Agnihotri, V. V., & Gorle, A. P. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111154 · Cited by 2
Generation of a blockage monoclonal antibody of LILRB1 against HLA-G
Shen, Y., Zhang, R., Jiang, X., & Yang, J. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106363 · Cited by 2
Sharma, V., & Kaur, J. (2023) · Asian Biomedicine · doi:10.2478/abm-2023-0047 · Cited by 3
“Recently, macrophages were demonstrated to support cancer cells by secreting some chemokines [13].”
BackgroundUrumarudappa, S. K. J., Tran, V., Oo, H. M., Suntiparpluacha, M., Sampattavanich, S., Rosa, V., Ruangritchankul, K., Ferreira, J. N., & Chaisuparat, R. (2023) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13488 · Cited by 2
Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer
CHIN, Y.-T., Tsai, C.-L., Ma, H.-H., Cheng, D., Tsai, C.-W., WANG, Y.-C., SHIH, H.-Y., Chang, S.-Y., Gu, J. H., Chang, W. S., et al. (2024) · Life · doi:10.3390/life14081035 · Cited by 2
Computational identification of migrating T cells in spatial transcriptomics data
Zhong, L., Li, B., Chi, Z., Zhang, S., Li, Q., & Xiao, G. (2026) · JCI Insight · doi:10.1172/jci.insight.192718 · Cited by 2
Biological Microniches Characterizing Pathological Lesions
Meraz, I. M., Segura-Ibarra, V., Leonard, F., Gonzalez, J., Ally, S., Godin, B., & Serda, R. E. (2013) · Frontiers of nanoscience · doi:10.1016/b978-0-08-098338-7.00006-6 · Cited by 3
Cancer bronchique et inflammation
Ruppert, A.-M., Rozensztajn, N., Viera, T., Antoine, M., Lavolé, A., Cadranel, J. L., & Wislez, M. (2015) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(16)30040-4 · Cited by 3
Mojsilović, S. S., Mojsilović, S. B., Bjelica, S., & Santibanez, J. F. (2018) · Analytical Cellular Pathology · doi:10.1155/2018/3134102 · Cited by 2
“For instance, TGF-β promotes macrophage polarization toward an M2-versus-M1 phenotype, which further promotes TGF-β production and deepens TGF-β-induced immunosuppression [4, 30, 31].”
Reprogramming of Tumor Microenvironment in Therapy
Jarosz–Biej, M., Smolarczyk, R., Cichoń, T., & Szala, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_22 · Cited by 3
Are M1 and M2 macrophages Effectual Players in Pathological Conditions?
Abdollahi, E., Saghafi, N., & Hasanzade, M. (2022) · Proceedings of Anticancer Research · doi:10.26689/par.v6i3.3962 · Cited by 1
“M1 macrophages are also characterized by the secretion of low levels of IL-10 and high levels of IL-12, as well as their capacity for antigen presentation ([16]).”
BackgroundMacrophage Response to Simulated Solar Radiation in the Development of Human Malignant Melanoma
Chu, S., Petukhova, T. A., Bordeaux, J. S., McCormick, T. S., & Cooper, K. D. (2021) · Archives of Clinical & Experimental Dermatology · doi:10.46527/2583-6374.119 · Cited by 1
E. coli Biomolecules Increase Glycolysis and Invasive Potential in Lung Adenocarcinoma
Vega, A. A., Shah, P. P., Rouchka, E. C., Clem, B. F., Dean, C. R., Woodrum, N., Tanwani, P., Siskind, L. J., & Beverly, L. J. (2025) · Cancers · doi:10.3390/cancers17030380 · Cited by 1
Unraveling the Role of Tumor-infiltrating Immune Cells in Modulating Cancer Drug Resistance
Mehrabadi, S. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206365310250310081445 · Cited by 2
Zhu, G., Yuan, W., Wang, K., Wu, H., Lv, K., Wang, X., Tuffour, A., Ren, B., Zhang, J., Jiang, C., et al. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00178 · Cited by 1
Understanding Cancer Biology and Microenvironment
Saha, A. K., Mahlawat, P., Kumar, M., & Koralkar, N. V. (2025) · Series in bioengineering · doi:10.1007/978-981-95-0457-2_2 · Cited by 1
Liu, T., Zhang, L., Li, Y., Liao, W., Deng, J., Liang, H., & Shen, F. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156348 · Cited by 1
Chowdhury, A. S., Reich, L. A., Liby, K. T., Yeh, E. S., & Leal, A. S. (2025) · Biomedicines · doi:10.3390/biomedicines14010080 · Cited by 1
“Among these immune cells, macrophages and T cells are especially critical in breast cancer progression and immune modulation [33–36].”
Yadav, M., Dahiya, M., Chauhan, S., Sharma, S., Rabbani, S. A., Senwar, K. R., Dhillon, A., & Kumar, S. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100264 · Cited by 2
Li, C., Rajasekar, P., Park, J., Lee, D., Kim, J.-C., Palanisamy, S., You, S., & Lee, D.-J. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108315 · Cited by 1
Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers
Oriquat, G., Abdulsahib, W. K., Ismail, S. H., Roopashree, R., Patro, P. S., Nellore, J., Mukherjee, G., Chauhan, A. S., & Musaeva, S. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06872-x · Cited by 1
“This pro-tumoral phenotype, often referred to as M2-like polarization, is consistently associated with poor prognosis across many cancer types, includ - ing various hematologic malignancies [54, 55].”
Khorsandi, K., Ghorayeb, L. E., VanNoy, E. L., & Haydar, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1788956 · Cited by 1
“This immunosuppressive signaling, coupled with the limited antigen-presenting capacity of M2-like TAMs, fosters a state of immune tolerance that allows tumor cells to escape immune surveillance (35, 36).”
Aouad, S., Kadiri, M., Allard, D., Skora, E., Giraud, L., Fuselier, C., du Roure, P. D., Mousson, A., Janvier, A., Baron, L., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013507 · Cited by 1
Dabagh, M., Ciceu, A., Baltă, C., Trotta, M. C., Ferraro, B., D’Amico, G., Hermenean, A. O., & Voiculescu, V. M. (2026) · Biological Research · doi:10.1186/s40659-026-00695-w · Cited by 1
“Gal-3, in particular, promotes macrophage polarization towards the M2 state by activating STAT3 and IL-10 signaling [116, 117].”
Firouzi, M., Akomea, A., Jamei, M. H., Harris, G. M., & Kim, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1937923 · Cited by 1
Toluquinol, A Marine Fungus Metabolite, Inhibits Some of the Hallmarks of Cancer
García‐Caballero, M., Medina, M. Á., & Quesada, A. R. (2014) · Springer eBooks · doi:10.1007/978-3-319-07145-9_14 · Cited by 1
Tasquinimod : ou comment agir sur le microenvironnement dans le cancer métastatique de la prostate
Houédé, N., & Irani, J. (2015) · The French Journal of Urology · doi:10.1016/j.purol.2015.01.008 · Cited by 1
Role of Cancer Stem Cells in Metastasis
Merchand‐Reyes, G., Pelayo, R., Pavón, L., Pestell, R. G., & Velasco-Velázquez, M. A. (2014) · Wiley eBooks · doi:10.1002/9781118356203.ch20 · Cited by 2
Endothelial and Accessory Cell Interactions in Neuroblastoma Tumor Microenvironment
Gershan, J. A., Chan, A. M.-L., Chrzanowska‐Wodnicka, M., Johnson, B. D., Robert, Q., & Ramchandr, R. (2013) · InTech eBooks · doi:10.5772/55486 · Cited by 1
“These factors include VEGF, placental growth factor (PIGF), arginase and the Tie2 angiopoietin cell surface receptor [203, 204].”
BackgroundCancer After Metastasis: The Second Transformation
Xu, Y., Cui, J., & Puett, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1381-7_11 · Cited by 1
Elias, M. A., Duarte, A., Nunes, T. P., Lourenço, A. M., Bráz, B. S., Vicente, G., Henriques, J. J. G. P., & Tavares, L. M. (2014) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2014.09.005 · Cited by 1
Inhibition of MMP-13 with modified polymer particles
Tran, H. Q., & Bratlie, K. M. (2015) · Surface Science · doi:10.1016/j.susc.2015.10.043 · Cited by 1
Psoriatic Arthritis Complicating Systemic Sclerosis: Possible Involvement of M2 Macrophages
Yamaoka, T., Inoue, T., Kitaba, S., Yokomi, A., Azukizawa, H., Terao, M., Murota, H., Higashiyama, M., & Katayama, I. (2015) · Annals of Dermatology · doi:10.5021/ad.2015.27.5.631 · Cited by 1
Chen, C., Huang, C., Hsieh, T., Chiu, W.-K., Chang, W.-L., & Shyr, C. (2016) · PubMed · Cited by 1
THE ROLE OF THE IL-17/IL-17R AXIS IN BREAST TUMOR GROWTH AND METASTASIS
Dawod, B. (2016) · DalSpace (Dalhousie University) · Cited by 1
Weagel, E. G. (2018) · ScholarsArchive (Brigham Young University) · Cited by 1
Sericin modified by gamma irradiation in solution and optimized for bioactivity
Kim, Y., Park, H., Lee, G. W., Kwon, M.-J., & Cho, Y. H. (2020) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2020.109137 · Cited by 1
Владимировна, П. А., Трухманов, А. С., Андреевна, С. О., Lyamina, S., Валерьевич, К. С., Pirogov, S. S., Пономарев, А. Б., Rumyantseva, D. E., Malyshev, I. Y., Maev, I. V., et al. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-1-24-33 · Cited by 1
Pozzo, A. R., Wechsler, J., Groult, J., Meda, L. D., Lebbé, C., & Mai, S. (2022) · Biomedicines · doi:10.3390/biomedicines10102391 · Cited by 1
Wei, L., Lin, L., Wang, J., Guan, X., Li, W., Gui, Y., Liao, S., Wang, M., Li, J., Deng, Y., et al. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01502-9 · Cited by 1
“…mediated by TAMs was relieved due to the decrease of TAMs [ 40, 41], the secretion of immunosuppression-related factors was reduced [ 42, 43], and the integrity of tumor interstitial was destroyed [ 44], so that more SAL-EPI could reach the depth of the tumor and achieve a virtuous…”
Wu, X., Chen, S., Ji, Q., Chen, H., & Chen, X. (2024) · Skin Research and Technology · doi:10.1111/srt.13739 · Cited by 1
“48,49 Accordingly, the inhibition Lastly,itisnotedthattheinvivoinvestigationislackedinthisstudy,and the IHC analysis is limited by the number of samples, as the available data in the Human Protein Atlas database may not comprehensively represent the entire spectrum of SKCM patients.”
BackgroundProstate Cancer and Inflammation
Hashemi, M., Tavakolipour, V., Morovatshoar, R., Samadpour, A., Asheghabadi, P. S., Hadadian, H., Bandsariyan, A., Ghasemi, Z., Orouei, S., AbolfathyNajmabady, N., et al. (2024) · Springer eBooks · doi:10.1007/978-981-97-4612-5_3 · Cited by 1
Giese, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-25832-4_2 · Cited by 1
“Also tumor-associated macrophages secrete many cytokines which promote immunosuppression [ 42 ].”
BackgroundAdhesion Molecule Regulation of Regulatory T Cell Migration
Loppnow, J. J. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee) · Cited by 1
Chakraborty, R., Leshem‐Lev, D., & Fixler, D. (2020) · Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications · doi:10.1117/12.2543937 · Cited by 1
“while at the stage of metastasis the population shifted to M2; M1 polarization was also reported to cause asthma[11, 12].”
BackgroundGarrido, E. (2015) · Americanae (AECID Library) · Cited by 1
INTERACTIONS BETWEEN PORPHYROMONAS GINGIVALIS AND MACROPHAGES IN ORAL PATHOLOGY
Belfield, L. (2013) · PEARL (University of Plymouth) · doi:10.24382/4112 · Cited by 1
[A study of low temperature catalyst for Sabatier reaction].
Ai, S. K., Zhou, D., Sun, J., Hou, W., & Zhou, K. (2000) · PubMed · Cited by 1
Li, C., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Research Square · doi:10.21203/rs.3.rs-142861/v1 · Cited by 1
Immunosuppressive phenotype of esophagus tumors stromaPreprint
Gratchev, A. N., Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., & Mochalnikova, V. V. (2020) · doi:10.21203/rs.3.rs-30657/v1 · Cited by 3
Filip, A. M., Lavickova, B., Hérault, A., Cubela, I., Ehret, B., Danenberg, E., Daniel, M. C., Chevrier, S., Coto‐Llerena, M., Protti, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.02.729459 · Cited by 1
Kim, E. K., Le, J. T., Moser, B., Phong, K. T., & Gartner, Z. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.05.742266 · Cited by 1
Combining oncolytic immunotherapy with conventional cancer treatments
Liikanen, I. (2015) · Helda - University of Helsinki Institutional Repository
Santos, A. M. R. D. V. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The Role of the Hedgehog Receptor Patched in LysM+ Cells in Mice
Pelczar, P. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4200
CD40L Gene Therapy for Solid Tumors
Liljenfeldt, L. (2014) · Uppsala University Publications (Uppsala University)
de Oliveira, C. E. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2013.tde-14102013-170536
THE ROLE OF MACROPHAGES IN THE PROGRESSION OF POLYCYSTIC KIDNEY DISEASE
Salah, S. M. (2014) · KU ScholarWorks (The University of Kansas)
Piano, M. D. (2013) · UEA Digital Repository (University of East Anglia)
Nizard, M. (2015) · theses.fr (ABES) · doi:10.70675/3d3079abz13a3z421bzb96ezd30e886c45b1 · Cited by 1
The role of Batf2 in LPS/IFNgamma polarized macrophages
Gehman, M. (2015) · UKnowledge (University of Kentucky) · Cited by 2
D'Almeida, S. M. (2015) · theses.fr (ABES) · doi:10.70675/92b9d3a7zb03dz4e4ezae4cz12285759bf0b
“44 aussi être impliquées dans le recrutement des TAM [174-176].”
BackgroundUnderstanding the Mechanism of Hard Metal (WC-Co) Toxicity: In vitro Studies and In vivo Exploration
Armstead, A. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5122
The role of syndecan-1 in the resolution of chronic inflammatory responses
Angsana, J. (2013) · SMARTech Repository (Georgia Institute of Technology)
Phenotypical and Functional Characterization of Polarized Human Macrophages
Iqbal, S. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-2744 · Cited by 1
Studies on Enhancement of Phagocytosis and Cytotoxicity in Macrophages by IL-18-Stimulation.
Xu, H., & 徐, 賀. (2014) · Institutional Repositories DataBase (IRDB)
Initial characterization of tumor heterogeneity in a syngeneic breast cancer model
Bahador, M. (2015) · BIBSYS Brage (BIBSYS (Norway))
Lima, J. D. C. C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-12082016-100836
Cisplatin partially impedes lung adenocarcinoma-mediated M2 macrophage polarization
Conway, E. M. (2016) · cIRcle (University of British Columbia) · doi:10.14288/1.0223348
The Roles of Necroptosis in the Pathogenesis of Staphylococcus aureus Infection
Kitur, K. (2016) · doi:10.7916/d8dr2vk2
“M1 macrophages express IFN-regulatory factor 5 (IRF5) and their surface markers include CD86 and CD80 (39, 40).”
BackgroundAuthentic Vascular and Stromal Structure in Animal Disease Model for Nanomedicine
Nishihara, H., & Kano, M. R. (2016) · Fundamental biomedical technologies · doi:10.1007/978-3-319-43525-1_6
Mesenchymal Stem/Stromal Cells and the Tumor Immune System
Walker, N. D., Nahas, G. R., Munoz, J. L., Lucas, J., Pobiarzyn, P. W., & Rameshwar, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803102-5.00017-3 · Cited by 1
Rached, M.-T. (2014) · Spiral (Imperial College London) · doi:10.25560/38448
Alsharif, S. (2015) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 4
Potential Anticancer Drugs Targeting Immune Pathways
Das, S., Biswas, J., & Choudhuri, S. K. (2016) · InTech eBooks · doi:10.5772/65352
“Met-CCL5 (receptor antagonist of CCL5) significantly reduces the number of macrophage infiltration at tumor site and promotes tumor regression [16].”
BackgroundInfluentialPerfil de expressão gênica da micróglia humana e suas alterações relacionadas ao glioma
Galatro, T. F. D. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-17112016-164342 · Cited by 1
Rackov, G. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bocuk, D. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6075
Staging and tumor biological mechanisms of lymph node metastasis in invasive urinary bladder cancer
Aljabery, F. A.-S. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-137474
Modelling of macrophage interactions by partial differential equations
Admon, M. R., & Maan, N. (2017) · Malaysian Journal of Fundamental and Applied Sciences · doi:10.11113/mjfas.v13n2.565
Miller, K. (2016) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.